236 related articles for article (PubMed ID: 35787294)
1. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.
Liu T; Woo JA; Bukhari MZ; Wang X; Yan Y; Buosi SC; Ermekbaeva A; Sista A; Kotsiviras P; LePochat P; Chacko A; Zhao X; Kang DE
Acta Neuropathol Commun; 2022 Jul; 10(1):95. PubMed ID: 35787294
[TBL] [Abstract][Full Text] [Related]
2. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 and PINK1 mediate CHCHD10
Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
[TBL] [Abstract][Full Text] [Related]
4. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
[TBL] [Abstract][Full Text] [Related]
5. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE
Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.
Liu T; Wetzel L; Zhu Z; Kumaraguru P; Gorthi V; Yan Y; Bukhari MZ; Ermekbaeva A; Jeon H; Kee TR; Woo JA; Kang DE
Cells; 2023 Dec; 12(24):. PubMed ID: 38132101
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
[TBL] [Abstract][Full Text] [Related]
9. CHCHD10
Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
[TBL] [Abstract][Full Text] [Related]
11. Structures of the Wild-Type and S59L Mutant CHCHD10 Proteins Important in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
ACS Chem Neurosci; 2022 Apr; 13(8):1273-1280. PubMed ID: 35349255
[TBL] [Abstract][Full Text] [Related]
12. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
13. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
[TBL] [Abstract][Full Text] [Related]
14. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
[TBL] [Abstract][Full Text] [Related]
15. CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.
Shammas MK; Nie Y; Gilsrud A; Huang X; Narendra DP; Chinnery PF
Hum Mol Genet; 2023 Dec; 33(1):91-101. PubMed ID: 37815936
[TBL] [Abstract][Full Text] [Related]
16. The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
Xu YF; Prudencio M; Hubbard JM; Tong J; Whitelaw EC; Jansen-West K; Stetler C; Cao X; Song J; Zhang YJ
PLoS One; 2013; 8(7):e69864. PubMed ID: 23922830
[TBL] [Abstract][Full Text] [Related]
17. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
[TBL] [Abstract][Full Text] [Related]
18. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.
Xu YF; Zhang YJ; Lin WL; Cao X; Stetler C; Dickson DW; Lewis J; Petrucelli L
Mol Neurodegener; 2011 Oct; 6():73. PubMed ID: 22029574
[TBL] [Abstract][Full Text] [Related]
19. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.
van Hummel A; Sabale M; Przybyla M; van der Hoven J; Chan G; Feiten AF; Chung RS; Ittner LM; Ke YD
Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12902. PubMed ID: 36951214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]